Dr Toh Han Chong is Deputy Medical Director, National Cancer Centre Singapore (NCCS), Associate Professor at the Cancer & Stem Cell Biology Program, SingHealth-Duke Global Health Institute, and Director of Cancer Immunotherapy, SingHealth-Duke-NUS Cell Therapy Centre.
Dr Toh graduated from the University of London, UK, with an Intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, United Kingdom. Dr Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, and at the Massachusetts General Hospital, Harvard Medical School, Boston, USA. He then completed a research fellowship in cancer immunotherapy at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. He is alumni of the Harvard Business School General Management Program.
Dr Toh received the National Outstanding Clinician Scientist Award 2018 for developing and building a cancer immunotherapy programme in Singapore. Dr Toh is a council member of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association, co-founder of the Asia-Pacific Gastroenterology Cancer Summit, and is on the Cancer Immunology faculty of the European Society of Medical Oncology. He has published over 120 peer review papers.